scholarly journals Neuronal modeling of alternating hemiplegia of childhood reveals transcriptional compensation and replicates a trigger-induced phenotype

2020 ◽  
Vol 141 ◽  
pp. 104881 ◽  
Author(s):  
John P. Snow ◽  
Grant Westlake ◽  
Lindsay K. Klofas ◽  
Soyoun Jeon ◽  
Laura C. Armstrong ◽  
...  
2013 ◽  
Vol 44 (02) ◽  
Author(s):  
K Brockmann ◽  
H Rosewich ◽  
H Thiele ◽  
U Maschke ◽  
P Huppke ◽  
...  

Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S356-S357
Author(s):  
Mary E. Moya-Mendez ◽  
Chiagoziem Ogbonna ◽  
Lauren Parker ◽  
Jordan E. Ezekian ◽  
Lyndsey Prange ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (5) ◽  
pp. e0127045 ◽  
Author(s):  
Louis Viollet ◽  
Gustavo Glusman ◽  
Kelley J. Murphy ◽  
Tara M. Newcomb ◽  
Sandra P. Reyna ◽  
...  

Cephalalgia ◽  
2008 ◽  
Vol 28 (8) ◽  
pp. 887-891 ◽  
Author(s):  
B de Vries ◽  
AH Stam ◽  
F Beker ◽  
AMJM van den Maagdenberg ◽  
KRJ Vanmolkot ◽  
...  

Familial hemiplegic migraine (FHM) and alternating hemiplegia of childhood (AHC) are severe neurological disorders that share clinical features. Therefore, FHM genes are candidates for AHC. We performed mutation analysis in the CACNA1A gene in a monozygotic twin pair with clinical features overlapping with both AHC and FHM and identified a novel de novo CACNA1A mutation. We provide the first evidence that a CACNA1A mutation can cause atypical AHC, indicating an overlap of molecular mechanisms causing AHC and FHM. These results also suggest that CACNA1A mutation scanning is indicated in patients with a severe neurological phenotype that includes paroxysmal (alternating) hemiplegia.


PLoS ONE ◽  
2015 ◽  
Vol 10 (8) ◽  
pp. e0137370
Author(s):  
Louis Viollet ◽  
Gustavo Glusman ◽  
Kelley J. Murphy ◽  
Tara M. Newcomb ◽  
Sandra P. Reyna ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Philippe A. Salles ◽  
Ignacio F. Mata ◽  
Tobias Brünger ◽  
Dennis Lal ◽  
Hubert H. Fernandez

The Na+/K+ ATPases are Sodium-Potassium exchanging pumps, with a heteromeric α-β-γ protein complex. The α3 isoform is required as a rescue pump, after repeated action potentials, with a distribution predominantly in neurons of the central nervous system. This isoform is encoded by the ATP1A3 gene. Pathogenic variants in this gene have been implicated in several phenotypes in the last decades. Carriers of pathogenic variants in this gene manifest neurological and non-neurological features in many combinations, usually with an acute onset and paroxysmal episodes triggered by fever or other factors. The first three syndromes described were: (1) rapid-onset dystonia parkinsonism; (2) alternating hemiplegia of childhood; and, (3) cerebellar ataxia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS syndrome). Since their original description, an expanding number of cases presenting with atypical and overlapping features have been reported. Because of this, ATP1A3-disorders are now beginning to be viewed as a phenotypic continuum representing discrete expressions along a broadly heterogeneous clinical spectrum.


1993 ◽  
Vol 122 (5) ◽  
pp. 673-679 ◽  
Author(s):  
Marle Bourgeois ◽  
Jean Aicardi ◽  
Françoise Goutières

Sign in / Sign up

Export Citation Format

Share Document